White label – Pompe disease - ClinicalTrials.eu

Study on the Effectiveness of Sphenopalatine Block for Headache Relief in Patients with Subarachnoid Hemorrhage Using Lidocaine Hydrochloride

Recruiting

2 1 1 1
Investigated Drugs:
Esketamine Nasal Spray for Patients with Treatment-Resistant Bipolar Depression

Recruiting

2 1 1 1
Investigated Diseases:
- Bipolar disorder
Investigated Drugs:
- Esketamine
Study of Durvalumab for Patients with Early Stage or Locally Advanced Non-Small Cell Lung Cancer Not Suitable for Surgery

Recruiting

1 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Durvalumab
Study on the Diagnostic Performance of 68Ga-ABS011 PET/CT for Patients with Metastatic Breast Cancer

Recruiting

4 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
- Neoplasm malignant
Investigated Drugs:
- 68Ga-Nota-Abscint-Her2
Study on Cannabis Extract for Improving Quality of Life in Patients with Alzheimer’s, Parkinson’s, or ALS Using Dronabinol and Cannabidiol

Recruiting

2 1
Investigated Diseases:
Investigated Drugs:
- Dronabinol
- Cannabidiol
Study on Aldesleukin and Dendritic Cell Vaccine for Patients with Resected Stage IV Neuroendocrine Tumors and Soft Tissue Sarcoma

Recruiting

2 1 1 1
Investigated Diseases:
- Neuroendocrine tumour
- Soft tissue sarcoma
Investigated Drugs:
- Autologous Tumor Lysate-Loaded Dendritic Cells
- Aldesleukin
Long-Term Safety Study of Berotralstat for Patients with Hereditary Angioedema from Previous Trials

Recruiting

3 1 1 1
Investigated Diseases:
- Hereditary angioedema
Investigated Drugs:
- Berotralstat
+1
Study on Teicoplanin for Preventing Infections in Children with Acute Myeloid Leukemia

Recruiting

3 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- Teicoplanin
Study on the Safety and Effectiveness of OC-1 Therapy for Patients with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or Lymphoma

Recruiting

1 1 1
Investigated Diseases:
- T-cell type acute leukaemia
- Precursor T-lymphoblastic lymphoma/leukaemia recurrent
Investigated Drugs:
- Autologous T-Cells Ex Vivo Modified With A Lentiviral Vector Encoding A Chimeric Antigen Receptor Specific For Cd1A
Study of IPH5201 and Durvalumab for Pre- and Post-Surgery Treatment in Patients with Early-Stage Non-Small Cell Lung Cancer

Recruiting

2 1 1 1 1
Investigated Diseases:
- Non-small cell lung cancer stage II
- Non-small cell lung cancer stage III
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies